FDA regulatory context, and consumer verification steps for men evaluating doctor-prescribed ED medication access online in ...
A randomized trial finds weekly extended-release buprenorphine yields neonatal outcomes comparable to sublingual treatment.
BioNxt Solutions has outlined a definitive timeline for the next stage of development for its sublingual drug delivery technology. The company's lead candidate, BNT23001, is a thin-film formulation of ...
Reaffirms guidance to resubmit the Anaphylm NDA in Q3 2026Received clarifying feedback from the FDA on pharmacokinetic (PK) and human factor (HF) ...
VANCOUVER, BC / ACCESS Newswire / March 24, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery ...
BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company built on artificial intelligence (“AI”) to develop transformative medicines in neuroscience, today announced that the U.S. Food ...
BlueChew, Rugiet, Ro—so many brands now offer direct-to-consumer erectile dysfunction meds over the Internet. Young men are ...
Ireland has one of the longest grass pollen seasons in the world, and one in four of us suffer the consequences. But hay ...
Supplemental New Drug Application for at-home Igalmi aims to provide a self-administered option for agitation in schizophrenia and bipolar disorder.
Wellbeing Magazine on MSN
How do ED medications work in the body?
Erectile dysfunction (ED) medications are designed to support the natural process that allows blood to flow into the penis ...
VANCOUVER, BC / ACCESS Newswire / March 30, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results